Key points are not available for this paper at this time.
Abstract Amorphous calcium phosphate (ACP) as a bone mineral precursor shows vast potential in the treatment of bone defects; however, its strong propensity to crystallize presents a major challenge during therapeutic applications. To mimic the in vivo stabilization of ACP by non‐collagenous proteins, an advanced polymer hydrogel (PAASP hydrogel) with unique repeated dicarboxylic units and high mechanical matrix strength is developed to stabilize ACP for cranial defect treatment. The synergy of high calcium ions chelation strength and hydrogen bonds toughened network in PAASP hydrogel can significantly delay the crystallization process of calcium phosphate and retard hydroxyapatite (HAP) formation, which leads to fast ions release to induce osteogenic differentiation, angiogenesis, collagen mineralization, and fast mineral apposition. In vivo, early osteogenic evaluation reveals that the PAASP hydrogel with stabilized ACP mediates the fastest mineral apposition rate and the largest diameter of collagen fibrils in the bone defect zone. Compared to the widely‐used HAP‐loaded hydrogel (new bone coverage ratio of 53%), the ACP‐loaded PAASP hydrogel can obviously promote new bone formation with a new bone coverage ratio of 88% in a rat cranial defect model. This work advances the current understanding of ACP stabilization and offers valuable insights for designing ACP‐based bone regeneration materials.
Zhang et al. (Thu,) studied this question.